Mölnlycke Health Care, commonly referred to as Mölnlycke, is a leading global provider of wound care and surgical solutions, headquartered in Sweden (SE). Founded in 1849, the company has established a strong presence in Europe, North America, and Asia, focusing on innovative products that enhance patient outcomes. Mölnlycke is renowned for its advanced wound care products, including the Mepilex® range of foam dressings and the Safetac® technology, which minimises pain during dressing changes. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, achieving notable milestones such as ISO certification and recognition for its sustainability efforts. With a robust market position, Mölnlycke continues to lead the industry by prioritising patient safety and comfort, making significant contributions to the fields of wound management and surgical care.
How does Molnlycke's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Molnlycke's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Mölnlycke Health Care reported total greenhouse gas emissions of approximately 549,129,000 kg CO2e. This includes 52,356,000 kg CO2e from Scope 1 emissions, 10,513,000 kg CO2e from Scope 2 emissions (market-based), and a significant 486,261,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (312,323,000 kg CO2e) and upstream transportation and distribution (41,254,000 kg CO2e). Mölnlycke has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 50% by 2030, using 2016 as the baseline. This target is reiterated in their 2021 sustainability report and is aligned with the Science Based Targets initiative (SBTi). Additionally, they plan to achieve a 20% reduction in absolute Scope 3 emissions by 2028 from a 2021 base year. Long-term goals include reaching net-zero emissions across the value chain by 2050, with specific targets of reducing Scope 1 and 2 emissions by 90% and Scope 3 emissions by 97% per ton of sold product by the same year. Mölnlycke also commits to sourcing 100% renewable electricity by 2024, up from 23% in 2021, and ensuring that 63% of their suppliers have science-based targets by 2028. These commitments reflect Mölnlycke's proactive approach to addressing climate change and reducing their carbon footprint in the healthcare sector, headquartered in Sweden.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 31,751,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 50,910,000 | 00,000,000 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 200 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Molnlycke's Scope 3 emissions, which increased by 9% last year and increased significantly since 2017, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 64% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Molnlycke has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
